VERV - Why Beam Therapeutics Stock Is Getting Bought Today | Benzinga
Beam Therapeutics Inc (NASDAQ: BEAM) shares are trading higher Tuesday after Eli Lilly And Co (NYSE: LLY) agreed to acquire certain rights under Beam's agreement with Verve Therapeutics Inc (NASDAQ: VERV).
What Happened: Eli Lilly said it will acquire rights under Beam's amended collaboration and license agreement with Verve, including rights to co-develop and co-commercialize Verve's base editing ...